×
-0.00187969924812026 0.00187969924812026 0.00751879699248121 0.0187969924812029 0.0274060150375941 0.0432330827067668 0.0414661654135339 0.0342105263157895
Stockreport

Celldex Therapeutics Finishes 2017 With Plenty of Cash and High Hopes [The Motley Fool]

CELLDEX THERAPEUTICS (CLDX)  More Company Research Source: The Motley Fool
Last celldex therapeutics earnings: 8/8 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.celldex.com
PDF The clinical-stage biotech awaits big news on its lead candidate in the second quarter of 2018. It's not your standard earnings release when a clinical-stage biotech announces a quarterly update. Usually, financial results aren't nearly as important as pipeline news. That was certainly the case for Celldex Therapeutics ( NASDAQ:CLDX ) in November, when the company reported its third-quarter results . And it was the same story on Wednesday, when Celldex announced its fourth-quarter and full-year 2017 results. Although the biotech provided an update on its financial condition, the most important story related to several key pipeline developments. Here are the highlights from the fourth-quarter update.  Image source: Getty Images. Celldex results: The raw numbers Metric  Q4 2017  Q4 2016  Year-Over-Year Change Revenue $3.45 million $1.87 million 84.4% Net loss ($3.84 million) ($32.31 million) N/A [Read more]

IMPACT SNAPSHOT EVENT TIME: CLDX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
CLDX alerts

from News Quantified
Opt-in for
CLDX alerts

from News Quantified